Anti-snoring Devices Market by Device Type (Oral Appliances, Nasal Devices, Position Control Devices), Gender (Male, Female), Age (Between 40-60, above 60), Distribution Channel (Online, Retail), End User (Homecare, Hospital) - Global Forecast to 2029

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key industry insights
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 1: Company revenue estimation approach
    • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
    • 2.2.1.3 Approach 3: Patient-based approach
    • 2.2.1.4 Growth forecast
    • 2.2.1.5 CAGR projections
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 MARKET SHARE ASSUMPTIONS
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ANTI-SNORING DEVICES MARKET OVERVIEW
• 4.2 GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing prevalence of sleep disorders
    • 5.2.1.2 Increasing geriatric population and subsequent rise in obesity
    • 5.2.1.3 Growing cigarette & alcohol consumption
    • 5.2.1.4 Rising technological advancements in anti-snoring devices
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High price of customized oral appliances
    • 5.2.2.2 Unreliable efficacy and inadequate studies for utilization of anti-snoring devices
    • 5.2.2.3 Social stigma associated with snoring
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Expanding undiagnosed population
    • 5.2.3.2 High growth potential of emerging markets
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Complex referral pathways and long waiting periods
• 5.3 PRICING ANALYSIS
  • 5.3.1 AVERAGE SELLING PRICE OF ANTI-SNORING DEVICES, BY KEY PLAYER
  • 5.3.2 AVERAGE SELLING PRICE TREND, BY DEVICE TYPE, 2021-2023
  • 5.3.3 AVERAGE SELLING PRICE TREND OF ANTI-SNORING DEVICES (ORAL APPLIANCES), BY REGION, 2021-2023 (USD)
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
  • 5.6.1 ANTI-SNORING DEVICES MARKET: ROLE IN ECOSYSTEM
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
  • 5.7.2 THREAT OF SUBSTITUTES
  • 5.7.3 BARGAINING POWER OF SUPPLIERS
  • 5.7.4 BARGAINING POWER OF BUYERS
  • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.8 REGULATORY ANALYSIS
  • 5.8.1 REGULATORY LANDSCAPE
    • 5.8.1.1 North America
      • 5.8.1.1.1 US
        • 5.8.1.1.1.1 Reimbursement scenario in US
      • 5.8.1.1.2 Canada
    • 5.8.1.2 Europe
    • 5.8.1.3 Asia Pacific
      • 5.8.1.3.1 Japan
      • 5.8.1.3.2 China
      • 5.8.1.3.3 India
      • 5.8.1.3.4 Australia
  • 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.8.2.1 North America
    • 5.8.2.2 Europe
    • 5.8.2.3 Asia Pacific
    • 5.8.2.4 Latin America
    • 5.8.2.5 Middle East & Africa
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Mandibular advancement devices
  • 5.9.2 ADJACENT TECHNOLOGIES
    • 5.9.2.1 Daytime-nighttime appliances
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA FOR HS CODE 901849, BY COUNTRY, 2019-2023 (USD MILLION)
  • 5.10.2 EXPORT DATA FOR HS CODE 901849, BY COUNTRY, 2019-2023 (USD MILLION)
• 5.11 PATENT ANALYSIS
• 5.12 KEY CONFERENCES & EVENTS, 2024-2025
• 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.14.2 BUYING CRITERIA
• 5.15 IMPACT OF AI/GENERATIVE AI ON ANTI-SNORING DEVICES MARKET
• 5.16 INVESTMENT & FUNDING SCENARIO
• 5.17 CASE STUDY ANALYSIS

6 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE

• 6.1 INTRODUCTION
• 6.2 ORAL APPLIANCES
  • 6.2.1 MANDIBULAR ADVANCEMENT DEVICES
    • 6.2.1.1 Ready-made mandibular advancement devices
      • 6.2.1.1.1 Low cost to fuel uptake
    • 6.2.1.2 Custom-made mandibular advancement devices
      • 6.2.1.2.1 High efficacy to drive market
• 6.3 TONGUE-RETAINING/STABILIZING DEVICES
  • 6.3.1 LOWER SUCCESS RATE OF TRDS TO RESTRAIN MARKET
• 6.4 NASAL DEVICES
  • 6.4.1 EXTERNAL NASAL DILATORS
    • 6.4.1.1 Convenient and non-invasive benefits to boost demand
  • 6.4.2 OTHER NASAL DEVICES
• 6.5 POSITION CONTROL DEVICES
• 6.6 CHIN STRAPS
• 6.7 EPAP THERAPY DEVICES

7 ANTI-SNORING DEVICES MARKET, BY GENDER

• 7.1 INTRODUCTION
• 7.2 MALE PATIENTS
  • 7.2.1 HIGHER PREVALENCE OF OSA OWING TO ANATOMY VARIATIONS TO PROPEL MARKET
• 7.3 FEMALE PATIENTS
  • 7.3.1 RISING CASES OF UNDIAGNOSED OSA TO DRIVE MARKET

8 ANTI-SNORING DEVICES MARKET, BY AGE GROUP

• 8.1 INTRODUCTION
• 8.2 BELOW 40 YEARS
  • 8.2.1 LOW PREVALENCE OF OSA AMONG YOUNGER INDIVIDUALS TO RESTRAIN MARKET
• 8.3 BETWEEN 40-60 YEARS
  • 8.3.1 INCREASING INCIDENCE OF CVD AND HYPERTENSION TO PROPEL MARKET
• 8.4 ABOVE 60 YEARS
  • 8.4.1 CHANGING SLEEPING PATTERNS TO SUPPORT MARKET GROWTH

9 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL

• 9.1 INTRODUCTION
• 9.2 ONLINE PHARMACIES
  • 9.2.1 GROWING PREFERENCE FOR DIRECT DISTRIBUTION CHANNELS TO DRIVE MARKET
• 9.3 RETAIL PHARMACIES
  • 9.3.1 CONVENIENT ACCESSIBILITY TO PRODUCTS TO PROPEL MARKET
• 9.4 HOSPITAL PHARMACIES
  • 9.4.1 GROWING FOCUS ON PATIENT CONVENIENCE TO FUEL UPTAKE

10 ANTI-SNORING DEVICES MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 HOME CARE SETTINGS
  • 10.2.1 GROWING PATIENT PREFERENCE FOR ADVANCED SLEEP MONITORING DEVICES TO PROPEL MARKET
• 10.3 HOSPITALS & CLINICS
  • 10.3.1 RAPID DEVELOPMENT IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET

11 ANTI-SNORING DEVICES MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 Rising trend of remote sleep testing to fuel uptake
  • 11.2.3 CANADA
    • 11.2.3.1 Increasing number of research grants for sleep apnea devices to boost demand
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 High prevalence of smoking to boost demand
  • 11.3.3 UK
    • 11.3.3.1 Rising awareness and increasing number of sleep service groups to support market growth
  • 11.3.4 FRANCE
    • 11.3.4.1 Rising geriatric population to fuel uptake
  • 11.3.5 ITALY
    • 11.3.5.1 Favorable initiatives for treatment of OSA to support market growth
  • 11.3.6 SPAIN
    • 11.3.6.1 Increasing initiatives for social awareness by regional organizations for treatment to drive market
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 CHINA
    • 11.4.2.1 Growing adult obesity rates and expanding geriatric population to propel market
  • 11.4.3 JAPAN
    • 11.4.3.1 Rising demand for cloud-connected OSA therapy devices to boost demand
  • 11.4.4 AUSTRALIA
    • 11.4.4.1 Rising R&D initiatives for innovative sleep therapy devices to boost demand
  • 11.4.5 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Favorable reimbursement policies for advanced sleep apnea procedures to drive market
  • 11.5.3 MEXICO
    • 11.5.3.1 Poor healthcare infrastructure to limit market growth
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 PRESENCE OF GLOBAL PLAYERS AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
  • 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 11.7 GCC COUNTRIES
  • 11.7.1 HIGH OBESITY RATES TO SUPPORT MARKET GROWTH
  • 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ANTI-SNORING DEVICES MARKET
• 12.3 REVENUE ANALYSIS, 2019-2023
• 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.4.1 RANKING OF KEY MARKET PLAYERS
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.5.5.1 Company footprint
    • 12.5.5.2 Region footprint
    • 12.5.5.3 Device footprint
    • 12.5.5.4 Distribution channel footprint
    • 12.5.5.5 End-user footprint
• 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 RESPONSIVE COMPANIES
  • 12.6.3 DYNAMIC COMPANIES
  • 12.6.4 STARTING BLOCKS
  • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 12.7 COMPANY VALUATION & FINANCIAL METRICS
  • 12.7.1 FINANCIAL METRICS
  • 12.7.2 COMPANY VALUATION
• 12.8 BRAND/PRODUCT COMPARISON
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES & APPROVALS
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS
  • 12.9.4 OTHER DEVELOPMENTS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 RESMED
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Deals
      • 13.1.1.3.2 Expansions
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses & competitive threats
  • 13.1.2 SOMNOMED
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 MnM view
      • 13.1.2.3.1 Key strengths
      • 13.1.2.3.2 Strategic choices
      • 13.1.2.3.3 Weaknesses & competitive threats
  • 13.1.3 PROSOMNUS SLEEP TECHNOLOGIES
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Deals
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Key strengths
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses & competitive threats
  • 13.1.4 VIVOS THERAPEUTICS, INC.
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product approvals
      • 13.1.4.3.2 Deals
      • 13.1.4.3.3 Expansions
      • 13.1.4.3.4 Other developments
  • 13.1.5 DYNAFLEX
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Deals
  • 13.1.6 OPENAIRWAY
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Deals
  • 13.1.7 PANTHERA DENTAL
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Product launches
      • 13.1.7.3.2 Deals
      • 13.1.7.3.3 Other developments
  • 13.1.8 AIRWAY MANAGEMENT
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product launches
  • 13.1.9 APNEA SCIENCES
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
  • 13.1.10 ORAVANOSA
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
  • 13.1.11 MYERSON LLC
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products offered
  • 13.1.12 BRAEBON MEDICAL CORPORATION
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products offered
• 13.2 OTHER PLAYERS
  • 13.2.1 MPOWRX HEALTH & WELLNESS PRODUCTS
  • 13.2.2 THE SNORE RELIEVER COMPANY, LLC
  • 13.2.3 TOMED GMBH
  • 13.2.4 THE AURUM GROUP
  • 13.2.5 OSCIMED SA
  • 13.2.6 SICAT GMBH & CO. KG
  • 13.2.7 GLIDEWELL
  • 13.2.8 APNOMED, INC.
  • 13.2.9 ZQUIET
  • 13.2.10 DREAM SYSTEMS DENTAL SLEEP LAB
  • 13.2.11 PURE SLEEP COMPANY
  • 13.2.12 THERAVENT, INC.
  • 13.2.13 INNOVATIVE HEALTH TECHNOLOGIES

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS

List of Tables

• TABLE 1 ANTI-SNORING DEVICES MARKET: INCLUSIONS & EXCLUSIONS
• TABLE 2 ANTI-SNORING DEVICES MARKET: RISK ASSESSMENT ANALYSIS
• TABLE 3 PREVALENCE OF SLEEP APNEA, BY COUNTRY, 2022-2024
• TABLE 4 KEY STATISTICS ON AGING POPULATION
• TABLE 5 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING SNORING
• TABLE 6 INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS OF UNTREATED SLEEP APNEA AND SNORING
• TABLE 7 INADEQUATE EFFICACY STUDIES ASSOCIATED WITH USE OF ANTI-SNORING DEVICES
• TABLE 8 KEY STATISTICS ON SNORING POPULATION
• TABLE 9 HIGH GROWTH POTENTIAL IN EMERGING MARKETS DUE TO UNDIAGNOSED POPULATION
• TABLE 10 AVERAGE SELLING PRICE OF ANTI-SNORING DEVICES, BY KEY PLAYER
• TABLE 11 AVERAGE SELLING PRICE TREND, BY DEVICE TYPE, 2021-2023
• TABLE 12 AVERAGE SELLING PRICE TREND OF ANTI-SNORING DEVICES (ORAL APPLIANCES), BY REGION, 2021-2023 (USD)
• TABLE 13 ANTI-SNORING DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
• TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
• TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
• TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES
• TABLE 18 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 19 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 20 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 21 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 22 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 23 ANTI-SNORING DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2024-2025
• TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ANTI-SNORING DEVICES (%)
• TABLE 25 KEY BUYING CRITERIA FOR END USERS OF ANTI-SNORING DEVICES
• TABLE 26 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 27 ORAL APPLIANCES OFFERED BY KEY PLAYERS
• TABLE 28 ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 29 ORAL APPLIANCES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 30 NORTH AMERICA: ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 31 NORTH AMERICA: ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2029 (THOUSAND UNITS)
• TABLE 32 EUROPE ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 33 EUROPE: ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2029 (THOUSAND UNITS)
• TABLE 34 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 35 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2029 (THOUSAND UNITS)
• TABLE 36 LATIN AMERICA: ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 37 MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS
• TABLE 38 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 39 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 40 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 41 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 42 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 43 LATIN AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 44 READY-MADE MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS
• TABLE 45 READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 46 NORTH AMERICA: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 47 EUROPE: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 48 ASIA PACIFIC: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 49 LATIN AMERICA: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 50 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS
• TABLE 51 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 52 NORTH AMERICA: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 53 EUROPE: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 54 ASIA PACIFIC: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 55 LATIN AMERICA: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 56 TONGUE-RETAINING DEVICES OFFERED BY KEY PLAYERS
• TABLE 57 TONGUE-RETAINING/STABILIZING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 58 NORTH AMERICA: TONGUE-RETAINING/STABILIZING DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 59 EUROPE: TONGUE-RETAINING/STABILIZING DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 60 ASIA PACIFIC: TONGUE-RETAINING/STABILIZING DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 61 LATIN AMERICA: TONGUE-RETAINING/STABILIZING DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 62 NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 63 NASAL DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 64 NORTH AMERICA: NASAL DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 65 EUROPE: NASAL DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 66 ASIA PACIFIC: NASAL DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 67 LATIN AMERICA: NASAL DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 68 EXTERNAL NASAL DILATORS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 69 NORTH AMERICA: EXTERNAL NASAL DILATORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 70 EUROPE: EXTERNAL NASAL DILATORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 71 ASIA PACIFIC: EXTERNAL NASAL DILATORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 72 LATIN AMERICA: EXTERNAL NASAL DILATORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 73 OTHER NASAL DEVICES
• TABLE 74 OTHER NASAL DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 75 NORTH AMERICA: OTHER NASAL DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 76 EUROPE: OTHER NASAL DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 77 ASIA PACIFIC: OTHER NASAL DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 78 LATIN AMERICA: OTHER NASAL DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 79 POSITION CONTROL DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 80 NORTH AMERICA: POSITION CONTROL DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 81 EUROPE: POSITION CONTROL DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 82 ASIA PACIFIC: POSITION CONTROL DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 83 LATIN AMERICA: POSITION CONTROL DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 84 CHIN STRAPS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 85 NORTH AMERICA: CHIN STRAPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 86 EUROPE: CHIN STRAPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 87 ASIA PACIFIC: CHIN STRAPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 88 LATIN AMERICA: CHIN STRAPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 89 EPAP THERAPY DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 90 NORTH AMERICA: EPAP THERAPY DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 91 EUROPE: EPAP THERAPY DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 92 ASIA PACIFIC: EPAP THERAPY DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 93 LATIN AMERICA: EPAP THERAPY DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 94 PREVALENCE OF SLEEP APNEA, BY AGE GROUP AND GENDER
• TABLE 95 ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 96 ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 97 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 98 EUROPE: ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 99 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 100 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 101 ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 102 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 103 EUROPE: ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 104 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 105 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 106 PREVALENCE OF SLEEP APNEA, BY AGE GROUP (2022)
• TABLE 107 ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 108 ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS UNDER 40 YEARS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 109 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS UNDER 40 YEARS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 110 EUROPE: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS UNDER 40 YEARS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 111 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS UNDER 40 YEARS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 112 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS UNDER 40 YEARS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 113 ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS BETWEEN 40-60 YEARS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 114 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS BETWEEN 40-60 YEARS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 115 EUROPE: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS BETWEEN 40-60 YEARS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 116 ASIA PACIFIC: 40-60 YEARS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 117 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS BETWEEN 40-60 YEARS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 118 ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 119 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 120 EUROPE: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 121 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 122 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 123 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 124 ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 125 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 126 EUROPE: ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 127 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 128 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 129 ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 130 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 131 EUROPE: ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 132 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 133 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 134 ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 135 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 136 EUROPE: ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 137 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 138 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 139 ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 140 ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 141 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 142 EUROPE: ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 143 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 144 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 145 ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 146 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 147 EUROPE: ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 148 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 149 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 150 ANTI-SNORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 151 NORTH AMERICA: MACROECONOMIC INDICATORS
• TABLE 152 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 153 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 154 NORTH AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 155 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 156 NORTH AMERICA: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 157 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 158 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 159 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 160 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 161 KEY ANTI-SNORING PRODUCTS PROVIDED BY LEADING PLAYERS IN US
• TABLE 162 US: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 163 US: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 164 US: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 165 US: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 166 US: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 167 US: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 168 US: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 169 US: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 170 KEY ANTI-SNORING PRODUCTS PROVIDED BY LEADING PLAYERS IN CANADA
• TABLE 171 CANADA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 172 CANADA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 173 CANADA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 174 CANADA: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 175 CANADA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 176 CANADA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 177 CANADA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 178 CANADA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 179 EUROPE: MACROECONOMIC INDICATORS
• TABLE 180 EUROPE: ANTI-SNORING DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 181 EUROPE: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 182 EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 183 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 184 EUROPE: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 185 EUROPE: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 186 EUROPE: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 187 EUROPE: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 188 EUROPE: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 189 ANTI-SNORING PRODUCTS PROVIDED BY LEADING PLAYERS IN GERMANY
• TABLE 190 GERMANY: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 191 GERMANY: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 192 GERMANY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 193 GERMANY: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 194 GERMANY: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 195 GERMANY: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 196 GERMANY: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 197 GERMANY: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 198 UK: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 199 UK: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 200 UK: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 201 UK: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 202 UK: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 203 UK: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 204 UK: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 205 UK: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 206 MAJOR PLAYERS THAT ARE REIMBURSED BY SOCIAL SECURITY OF FRANCE
• TABLE 207 FRANCE: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 208 FRANCE: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 209 FRANCE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 210 FRANCE: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 211 FRANCE: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 212 FRANCE: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 213 FRANCE: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 214 FRANCE: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 215 ITALY: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 216 ITALY: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 217 ITALY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 218 ITALY: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 219 ITALY: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 220 ITALY: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 221 ITALY: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 222 ITALY: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 223 SPAIN: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 224 SPAIN: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 225 SPAIN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 226 SPAIN: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 227 SPAIN: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 228 SPAIN: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 229 SPAIN: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 230 SPAIN: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 231 REST OF EUROPE: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 232 REST OF EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 233 REST OF EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 234 REST OF EUROPE: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 235 REST OF EUROPE: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 236 REST OF EUROPE: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 237 REST OF EUROPE: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 238 REST OF EUROPE: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 239 ASIA PACIFIC: MACROECONOMIC INDICATORS
• TABLE 240 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 241 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 242 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 243 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 244 ASIA PACIFIC: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 245 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 246 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 247 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 248 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 249 CHINA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 250 CHINA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 251 CHINA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 252 CHINA: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 253 CHINA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 254 CHINA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 255 CHINA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 256 CHINA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 257 JAPAN: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 258 JAPAN: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 259 JAPAN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 260 JAPAN: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 261 JAPAN: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 262 JAPAN: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 263 JAPAN: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 264 JAPAN: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 265 AUSTRALIA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 266 AUSTRALIA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 267 AUSTRALIA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 268 AUSTRALIA: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 269 AUSTRALIA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 270 AUSTRALIA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 271 AUSTRALIA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 272 AUSTRALIA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 273 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 274 REST OF ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 275 REST OF ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 276 REST OF ASIA PACIFIC: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 277 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 278 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 279 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 280 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 281 LATIN AMERICA: MACROECONOMIC INDICATORS
• TABLE 282 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 283 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 284 LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 285 LATIN AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 286 LATIN AMERICA: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 287 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 288 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 289 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, B Y DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 290 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 291 BRAZIL: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 292 BRAZIL: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 293 BRAZIL: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 294 BRAZIL: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 295 BRAZIL: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 296 BRAZIL: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 297 BRAZIL: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 298 BRAZIL: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 299 MEXICO: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 300 MEXICO: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 301 MEXICO: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 302 MEXICO: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 303 MEXICO: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 304 MEXICO: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 305 MEXICO: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 306 MEXICO: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 307 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 308 REST OF LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 309 REST OF LATIN AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 310 REST OF LATIN AMERICA: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 311 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 312 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 313 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 314 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 315 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
• TABLE 316 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 317 MIDDLE EAST & AFRICA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 318 MIDDLE EAST & AFRICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 319 MIDDLE EAST & AFRICA: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 320 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 321 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 322 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 323 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 324 GCC COUNTRIES: MACROECONOMIC INDICATORS
• TABLE 325 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
• TABLE 326 GCC COUNTRIES: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 327 GCC COUNTRIES: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 328 GCC COUNTRIES: NASAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 329 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
• TABLE 330 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 331 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
• TABLE 332 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 333 OVERVIEW OF STRATEGIES DEPLOYED BY KEY ANTI-SNORING DEVICE MANUFACTURING COMPANIES
• TABLE 334 ANTI-SNORING DEVICES MARKET: DEGREE OF COMPETITION
• TABLE 335 ANTI-SNORING DEVICES MARKET: REGION FOOTPRINT
• TABLE 336 ANTI-SNORING DEVICES MARKET: DEVICE FOOTPRINT
• TABLE 337 ANTI-SNORING DEVICES MARKET: DISTRIBUTION CHANNEL FOOTPRINT
• TABLE 338 ANTI-SNORING DEVICES MARKET: END-USER FOOTPRINT
• TABLE 339 ANTI-SNORING DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
• TABLE 340 ANTI-SNORING DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
• TABLE 341 ANTI-SNORING DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-NOVEMBER 2024
• TABLE 342 ANTI-SNORING DEVICES MARKET: DEALS, JANUARY 2021-NOVEMBER 2024
• TABLE 343 ANTI-SNORING DEVICES MARKET: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
• TABLE 344 ANTI-SNORING DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021-NOVEMBER 2024
• TABLE 345 RESMED: COMPANY OVERVIEW
• TABLE 346 RESMED: PRODUCTS OFFERED
• TABLE 347 RESMED: DEALS, JANUARY 2021-NOVEMBER 2024
• TABLE 348 RESMED: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
• TABLE 349 SOMNOMED: COMPANY OVERVIEW
• TABLE 350 SOMNOMED: PRODUCTS OFFERED
• TABLE 351 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY OVERVIEW
• TABLE 352 PROSOMNUS SLEEP TECHNOLOGIES: PRODUCTS OFFERED
• TABLE 353 PROSOMNUS SLEEP TECHNOLOGIES: DEALS, JANUARY 2021-NOVEMBER 2024
• TABLE 354 VIVOS THERAPEUTICS, INC.: COMPANY OVERVIEW
• TABLE 355 VIVOS THERAPEUTICS, INC.: PRODUCTS OFFERED
• TABLE 356 VIVOS THERAPEUTICS, INC.: PRODUCT APPROVALS, JANUARY 2021-MARCH 2024
• TABLE 357 VIVOS THERAPEUTICS, INC.: DEALS, JANUARY 2021-NOVEMBER 2024
• TABLE 358 VIVOS THERAPEUTICS, INC.: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
• TABLE 359 VIVOS THERAPEUTICS, INC.: OTHER DEVELOPMENTS, JANUARY 2021-NOVEMBER 2024
• TABLE 360 DYNAFLEX: COMPANY OVERVIEW
• TABLE 361 DYNAFLEX: PRODUCTS OFFERED
• TABLE 362 DYNAFLEX: DEALS, JANUARY 2021-NOVEMBER 2024
• TABLE 363 OPENAIRWAY: COMPANY OVERVIEW
• TABLE 364 OPENAIRWAY: PRODUCTS OFFERED
• TABLE 365 OPENAIRWAY: DEALS, JANUARY 2021-NOVEMBER 2024
• TABLE 366 PANTHERA DENTAL: COMPANY OVERVIEW
• TABLE 367 PANTHERA DENTAL: PRODUCTS OFFERED
• TABLE 368 PANTHERA DENTAL: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
• TABLE 369 PANTHERA DENTAL: DEALS, JANUARY 2021-NOVEMBER 2024
• TABLE 370 PANTHERA DENTAL: OTHER DEVELOPMENTS, JANUARY 2021-NOVEMBER 2024
• TABLE 371 AIRWAY MANAGEMENT: COMPANY OVERVIEW
• TABLE 372 AIRWAY MANAGEMENT: PRODUCTS OFFERED
• TABLE 373 AIRWAY MANAGEMENT: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
• TABLE 374 APNEA SCIENCES: COMPANY OVERVIEW
• TABLE 375 APNEA SCIENCES: PRODUCTS OFFERED
• TABLE 376 ORAVANOSA: COMPANY OVERVIEW
• TABLE 377 ORAVANOSA: PRODUCTS OFFERED
• TABLE 378 MYERSON LLC: COMPANY OVERVIEW
• TABLE 379 MYERSON LLC: PRODUCTS OFFERED
• TABLE 380 BRAEBON MEDICAL CORPORATION: COMPANY OVERVIEW
• TABLE 381 BRAEBON MEDICAL CORPORATION: PRODUCTS OFFERED

List of Figures

• FIGURE 1 MARKETS & REGIONS COVERED
• FIGURE 2 ANTI-SNORING DEVICES MARKET: RESEARCH DESIGN
• FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
• FIGURE 5 BOTTOM-UP APPROACH: PATIENT-BASED ANALYSIS
• FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
• FIGURE 7 ANTI-SNORING DEVICES MARKET: TOP-DOWN APPROACH
• FIGURE 8 DATA TRIANGULATION METHODOLOGY
• FIGURE 9 ANTI-SNORING DEVICES MARKET: STUDY ASSUMPTIONS
• FIGURE 10 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2024 VS. 2029 (USD MILLION)
• FIGURE 11 ANTI-SNORING DEVICES MARKET, BY GENDER, 2024 VS. 2029 (USD MILLION)
• FIGURE 12 ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION)
• FIGURE 13 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD MILLION)
• FIGURE 14 ANTI-SNORING DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 15 ANTI-SNORING DEVICES MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
• FIGURE 16 INCREASING INCIDENCE OF SLEEP DISORDERS TO PROPEL MARKET
• FIGURE 17 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2024 VS. 2029 (USD MILLION)
• FIGURE 18 ORAL APPLIANCES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
• FIGURE 19 ANTI-SNORING DEVICES MARKET, BY GENDER, 2024 VS. 2029 (USD MILLION)
• FIGURE 20 ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION)
• FIGURE 21 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD MILLION)
• FIGURE 22 ANTI-SNORING DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 23 ANTI-SNORING DEVICES MARKET: ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
• FIGURE 24 ANTI-SNORING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES
• FIGURE 26 SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION IS THE PREFERRED STRATEGY OF PROMINENT COMPANIES
• FIGURE 27 ANTI-SNORING DEVICES MARKET: ECOSYSTEM ANALYSIS
• FIGURE 28 ANTI-SNORING DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ANTI-SNORING DEVICES PATENTS, JANUARY 2014-MARCH 2024
• FIGURE 30 ANTI-SNORING DEVICES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ANTI-SNORING DEVICES
• FIGURE 32 KEY BUYING CRITERIA FOR END USERS OF ANTI-SNORING DEVICES
• FIGURE 33 ANTI-SNORING DEVICES MARKET: INVESTMENT & FUNDING SCENARIO FOR KEY PLAYERS (2019-2024)
• FIGURE 34 NORTH AMERICA: ANTI-SNORING DEVICES MARKET SNAPSHOT
• FIGURE 35 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET SNAPSHOT
• FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN ANTI-SNORING DEVICES MARKET, 2021-2023 (USD MILLION)
• FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ANTI-SNORING DEVICES MARKET (2023)
• FIGURE 38 RANKING OF KEY PLAYERS IN ANTI-SNORING DEVICES MARKET, 2023
• FIGURE 39 ANTI-SNORING DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
• FIGURE 40 ANTI-SNORING DEVICES MARKET: COMPANY FOOTPRINT
• FIGURE 41 ANTI-SNORING DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
• FIGURE 42 EV/EBITDA OF KEY VENDORS
• FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• FIGURE 44 ANTI-SNORING DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
• FIGURE 45 RESMED: COMPANY SNAPSHOT (2024)
• FIGURE 46 SOMNOMED: COMPANY SNAPSHOT (2023)
• FIGURE 47 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY SNAPSHOT (2023)
• FIGURE 48 VIVOS THERAPEUTICS, INC.: COMPANY SNAPSHOT (2023)